A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo

Recruiting

Phase 1

TEV-53408A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo

Sponsor:

Teva Branded Pharmaceutical Products R&D LLC

Code:

NCT06625177

Conditions

Vitiligo

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TEV-53408

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-03. This information was provided to ClinicalTrials.gov by Teva Branded Pharmaceutical Products R&D LLC on 2025-09-25.